Clinical Trials Directory

Trials / Terminated

TerminatedNCT02068989

Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

Stress Hyperglycemia as an Indicator for Future Diabetes Mellitus: A Prospective Cohort Study

Status
Terminated
Phase
Study type
Observational
Enrollment
1 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.

Conditions

Timeline

Start date
2013-02-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-02-21
Last updated
2016-09-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02068989. Inclusion in this directory is not an endorsement.